Cineplex (TSE:CGX – Get Rating) had its target price lowered by stock analysts at Scotiabank from C$13.00 to C$11.50 in a note issued to investors on Friday, BayStreet.CA reports. Scotiabank’s target price would indicate a potential upside of 46.68% from the company’s previous close.
A number of other equities analysts also recently weighed in on CGX. Canaccord Genuity Group lowered their target price on shares of Cineplex from C$16.00 to C$13.00 in a research note on Thursday, November 3rd. TD Securities reduced their price target on shares of Cineplex from C$17.50 to C$15.50 and set a “buy” rating for the company in a report on Friday, November 11th. Finally, National Bankshares reduced their price target on shares of Cineplex from C$15.50 to C$13.00 and set an “outperform” rating for the company in a report on Monday, January 9th.
Cineplex Price Performance
Shares of TSE:CGX opened at C$7.84 on Friday. The company has a market cap of C$496.77 million and a price-to-earnings ratio of -2.47. The company has a debt-to-equity ratio of 7,933.30, a current ratio of 0.34 and a quick ratio of 0.22. The firm has a 50 day simple moving average of C$9.19 and a 200 day simple moving average of C$9.59. Cineplex has a one year low of C$7.30 and a one year high of C$14.10.
Cineplex Company Profile
Cineplex Inc, together with its subsidiaries, operates as an entertainment and media company in Canada and internationally. It operates through four segments: Film Entertainment and Content, Media, Amusement and Leisure, and Location-Based Entertainment. The company engages in theatre exhibition and theatre food service activities.
See Also
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For RecessionÂ
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here’s Why
- Carvana Stock Rally, Here’s What You Need to Know
Receive News & Ratings for Cineplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cineplex and related companies with MarketBeat.com's FREE daily email newsletter.